SCHEMBL8909637

SCHEMBL8909637

COc1ccc2c(c1)-c1cc3c(c(C)c1=N2)C(C)=C(C(=O)OCc1ccccc1)N=3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.40
KMT2A Q03164 3/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
DHODH Q02127 2/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
NPC1 O15118 2/20 0.37
ATM Q13315 1/20 0.37
PRNP P04156 1/20 0.37
AURKA O14965 1/20 0.36
THRB P10828 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1388713 0.88 TDP1 (0.40) TDP1KMT2APOLBL3MBTL1NPC1
SCHEMBL8909720 0.88 DHODH (0.38) TDP1KMT2ADHODHPOLBL3MBTL1
SCHEMBL8909595 0.88 DHODH (0.38) TDP1KMT2ADHODHPOLBL3MBTL1
SCHEMBL8910758 0.82 DHODH (0.38) TDP1KMT2ADHODHL3MBTL1NPC1
SCHEMBL8911173 0.81 TDP1 (0.39) TDP1KMT2APOLBL3MBTL1NPC1
SCHEMBL8909629 0.78 CA12 (0.39) TDP1KMT2ATP53MAPTALDH1A1
SCHEMBL8155106 0.75 MAOB (0.43) TDP1KMT2APOLBL3MBTL1MAPT
SCHEMBL8909809 0.75 TSHR (0.37) KMT2ACASP3SENP7L3MBTL1NPC1
SCHEMBL8150300 0.75 MAPK1 (0.33)
SCHEMBL8141669 0.73 MAPK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US claimed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed